| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |